You Won't Dare Claim You Understand AI Until You've Read the Doubao Money-Making Playbook
In the Age of AI, Jocks Rule
In the Age of AI, Jocks Rule
OpenClaw no longer lacks applause — what it needs is a hardware ecosystem that can sustain long-term growth.
Recording the Changes of April
An **AIR incubated company and Tongtou Family portfolio company**, **Shuimu Molecular** has emerged as one of the most promising benchmark enterprises in AI-driven drug discovery, pursuing a dual-engine strategy of "tool empowerment + proprietary pipeline development." Its core achievements include the ChatDD intelligent agent framework, the OpenBioMed open-source platform, Shuimu Zhiliao — a new consumer-facing "super brain" tool for life sciences — and multimodal large models.
From Technical Platform Validation to Clinical Value
Know the mistake, be willing to fix it, fix it fast.
Pragmatically advance autonomous freight transport from "concept" to "reality."
Global Fusion Commercialization Accelerates as China's Contenders Rise
Please, Pop Mart, Just Make Interactive Blind Boxes Already
Major Funding + Leading Model + Mass Production